Business

Prenetics to Participate in the 38th Annual ROTH Conference

NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the Company will participate in the 38th Annual ROTH Conference being held Sunday, March 22nd to Tuesday, March 24th at the Ritz-Carlton in Laguna Niguel, CA. Prenetics CEO Danny Yeung and President of Americas David Vanderveen will be available for one-on-one meetings throu

articlePrenetics Global LimitedMarch 18, 20262/company/prenetics-global-ltd/news/prenetics-to-participate-in-the-38th-annual-roth-conference
Prenetics to Participate in the 38th Annual ROTH Conference

About this update from Prenetics Global Limited

[{"type":"image","alt":"Prenetics Global Limited","displaySize":"","headline":null,"caption":"Prenetics Global Limited","className":"","disableSlideshowImg":false,"size":{"original":{"width":156,"height":29,"url":"https://media.zenfs.com/en/globenewswire.com/28cddcde45fd51107349fbcad1dc5db7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/thbLdQ40xTitzWmh7Xbggg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTM5O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/28cddcde45fd51107349fbcad1dc5db7","width":156,"height":29}},"lazy":false},{"type":"text","content":"NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the Company will participate in the 38th Annual ROTH Conference being held Sunday, March 22nd to Tuesday, March 24th at the Ritz-Carlton in Laguna Niguel, CA.","length":383,"tagName":"p"},{"type":"text","content":"Prenetics CEO Danny Yeung and President of Americas David Vanderveen will be available for one-on-one meetings throughout the conference. Management will also participate in a fireside chat at 8:30 a.m. PT and a Consumer Influencer panel discussion at 12:00 p.m. PT on Monday, March 23rd — both available via webcast at the links above and on the Company’s investor relations website.","length":384,"tagName":"p"},{"type":"text","content":"To schedule a one-on-one meeting with Prenetics’ management, please contact Investor Relations at [email protected] or your ROTH representative.","length":141,"tagName":"p"},{"type":"text","content":"About Prenetics","length":15,"tagName":"p"},{"type":"text","content":"Prenetics (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company’s flagship consumer brand, IM8, co-founded with David Beckham and championed by World No. 1 tennis player Aryna Sabalenka, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, achieving an impressive milestone of surpassing $100 million in annualized recurring revenue within just 11 months of operations, and is now sold in more than 30 countries worldwide.","length":634,"tagName":"p"},{"type":"text","conten...

More updates from Prenetics Global Limited

Prenetics CEO Danny YeungPreneticsDavid Beckhamthe Companyconsumer brandhealth sciences